Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis
ConditionDe Quervain Tenosynovitis
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, Davis
About this trial
The aim of the study is to determine whether or not extra-sheath steroid injections are inferior to intra-sheath steroid injections in the treatment of DeQuervain's Tenosynovitis.
Patients will be randomized to either the intra-sheath group or the extra-sheath group and their pre-injection level of pain will be assessed using the visual analog scale. Appropriate injections will then be administered by 1 of 3 UC Davis hand surgeons. Six weeks post injection the patients will be reassessed using the visual analog scale and their score at 6 weeks will be compared to their pre-injection score.
Eligibility criteria
Qualifiers
Signed informed consent from the patient exclusively and not a legal representative
Clinically diagnosed with De Quervain's
VAS score of at least 40mm pre-injection
Life expectancy greater than 1 year
Disqualifiers
Having previously undergone steroid injection in the treatment of De Quervain's
Having previously undergone surgery for De Quervain's in the affected wrist
Having previously undergone steroid injection and failed in the treatment of trigger finger
Allergies to lidocaine or dexamethasone
Trial design
Treatments tested in this trial
- Intra-sheath injection
- Extra-sheath injection
- Ultrasound
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov